Tenon Medical, Inc. Announces 1:35 Reverse Stock Split
Tenon Medical, Inc. (NASDAQ:TNON) announced a 1-for-35 reverse stock split of its common stock, effective August 10, 2026 before Nasdaq trading. Stockholders approved the split at the July 23, 2026 annual meeting to help meet Nasdaq’s $1.00 minimum average closing price requirement. Vstock Transfer will act as exchange agent; no fractional shares will be issued.
How this was made
The 30-second read
Why it matters
The reverse split is intended to meet Nasdaq Capital Market’s minimum $1.00 average closing price requirement. It will become effective Aug. 10, 2026 at 12:01 ET, with trading on a split-adjusted basis at the open.
Market read
This is a concrete corporate action with a specific effective date and purpose tied to continued Nasdaq listing, which can drive mechanical price/volume changes and sentiment shifts.
What to watch
Traders should account for split-adjusted charting, options/derivatives contract adjustments, and how fractional-share rounding and certificate exchange mechanics may affect short-term flows.
Background
Tenon Medical is a medical device company focused on sacro-pelvic disorders and announced a reverse split approved by stockholders on July 23, 2026.
Ticker impact
Tenon Medical announced a 1-for-35 reverse stock split effective Aug. 10, 2026 to raise its share price above Nasdaq’s $1 minimum.
Likely short-term volatility around the Aug. 10 effective date, with limited fundamental change implied by the split itself.
Reverse splits do not create value, but they often coincide with continued listing risk and can affect liquidity, investor perception, and per-share valuation multiples.
Market effects
Microcap medical device names on Nasdaq may see similar compliance-driven corporate actions, keeping a watch on reverse-split risk in the group.
Primarily US small-cap/Nasdaq liquidity and sentiment effects; limited spillover expected beyond comparable microcaps.
Low global relevance; the event is company-specific and tied to Nasdaq listing rules.
Counterpoint
The company frames the reverse split as a straightforward compliance step, so the market may over-discount it if fundamentals and product traction remain intact.
Key entities
- companyTenon Medical, Inc.
NASDAQ-listed medical device company executing a 1-for-35 reverse stock split for Nasdaq listing compliance.
- service_providerVstock Transfer, LLC
Transfer agent acting as exchange agent for the reverse stock split.
- venueNasdaq Capital Market
Listing venue with the $1.00 minimum average closing price requirement referenced by the company.
